Filing Flows › Inspire Medical Systems (INSP) › R&D spending
Inspire Medical Systems (INSP) R&D spending by quarter
Inspire Medical Systems' R&D spending was $22.2M in Q3 2026 (third quarter 2026), -10% from Q2 2026. Over the last 7 quarters it ranged from $22.2M (Q3 2026) to $27.8M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $22.2M | -10% | -8% |
| Q2 2026 | $24.7M | -4% | -6% |
| Q1 2026 | $25.8M | +4% | -7% |
| Q4 2025 | $24.9M | +3% | — |
| Q3 2025 | $24.2M | -8% | — |
| Q2 2025 | $26.2M | -6% | — |
| Q1 2025 | $27.8M | — | — |
Q3 2026 at a glance
Inspire Medical Systems, Q3 2026: revenue $207M (-8% year over year), operating margin -13.9%, net loss $24.4M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Inspire Medical Systems' R&D spending?
Inspire Medical Systems' R&D spending was $22.2M in Q3 2026 (third quarter 2026), -10% from Q2 2026.
How has Inspire Medical Systems' R&D spending changed?
Over the last 7 quarters it ranged from $22.2M (Q3 2026) to $27.8M (Q1 2025).
Q3 2026 results → · How Inspire Medical Systems makes money →